scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1026368866 |
P356 | DOI | 10.1007/S00415-014-7352-5 |
P932 | PMC publication ID | 4101047 |
P698 | PubMed publication ID | 24760339 |
P5875 | ResearchGate publication ID | 261839408 |
P50 | author | Keith A Josephs | Q90859127 |
Jennifer L Whitwell | Q99637904 | ||
Youngsin Jung | Q114336686 | ||
Dennis W. Dickson | Q30504740 | ||
Clifford Jack | Q30505709 | ||
Melissa E. Murray | Q42734330 | ||
Ronald C. Petersen | Q56839853 | ||
David S Knopman | Q63967707 | ||
Joseph E Parisi | Q67209577 | ||
Bradley F Boeve | Q67501037 | ||
P2860 | cites work | Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 |
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
Primate models of movement disorders of basal ganglia origin | Q29618489 | ||
TDP-43 is a key player in the clinical features associated with Alzheimer's disease | Q34232167 | ||
Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes | Q34604146 | ||
Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease | Q36115656 | ||
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease | Q37179756 | ||
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. | Q37425165 | ||
Staging TDP-43 pathology in Alzheimer's disease | Q37621617 | ||
Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies | Q46396965 | ||
A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease | Q48611085 | ||
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype | Q48864196 | ||
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. | Q53299106 | ||
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease | Q73789480 | ||
Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease | Q77614817 | ||
P433 | issue | 7 | |
P921 | main subject | Alzheimer's disease | Q11081 |
Parkinson's disease | Q11085 | ||
parkinsonian syndrome | Q1531991 | ||
P304 | page(s) | 1344-1348 | |
P577 | publication date | 2014-04-24 | |
P1433 | published in | Journal of Neurology | Q6295649 |
P1476 | title | TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism | |
P478 | volume | 261 |
Q92286200 | Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease |
Q50350613 | Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies. |
Q64385732 | Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. |
Q48287129 | Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. |
Q47727180 | Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration. |
Q38403182 | Progressive Supranuclear Palsy Syndrome and Semantic Dementia in Neuropathologically Proven Lewy Body Disease: A Report of Two Cases |
Q90318261 | Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease |
Q36217832 | TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features |
Q53366738 | TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. |
Q90379423 | TDP-43: From Alzheimer's Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy |
Q38529627 | The Role of TDP-43 in Alzheimer's Disease |
Q48949710 | Updated TDP-43 in Alzheimer's disease staging scheme |
Search more.